Items where authors include "Donovan, J.L."

Article

Watts, E.L. orcid.org/0000-0001-9229-2589, Gonzales, T.I. orcid.org/0000-0003-0085-8771, Strain, T. et al. (91 more authors) (2024) Observational and genetic associations between cardiorespiratory fitness and cancer: a UK Biobank and international consortia study. British Journal of Cancer, 130 (1). pp. 114-124. ISSN 0007-0920

Parker, A., Arundel, C., Mills, N. et al. (30 more authors) (2023) Staff training to improve participant recruitment into surgical randomised controlled trials: A feasibility study within a trial (SWAT) across four host trials simultaneously. Research Methods in Medicine & Health Sciences, 4 (1). pp. 2-15. ISSN 2632-0843

Lane, J.A., Donovan, J.L., Young, G.J. et al. (26 more authors) (2022) Functional and quality of life outcomes of localised prostate cancer treatments (Prostate Testing for Cancer and Treatment [ProtecT] study). BJU International, 130 (3). pp. 370-380. ISSN 1464-4096

Noble, S.M., Garfield, K., Lane, J.A. et al. (24 more authors) (2020) The ProtecT randomised trial cost-effectiveness analysis comparing active monitoring, surgery, or radiotherapy for prostate cancer. British Journal of Cancer, 123 (7). pp. 1063-1070. ISSN 0007-0920

Hamdy, F.C., Donovan, J.L., Lane, J.A. et al. (33 more authors) (2020) Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer : the ProtecT three-arm RCT. Health Technology Assessment, 24 (37). pp. 1-175. ISSN 1366-5278

Birtle, A., Johnson, M., Chester, J. et al. (21 more authors) (2020) Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial. The Lancet, 395 (10232). pp. 1268-1277. ISSN 0140-6736

Neal, D.E., Metcalfe, C., Donovan, J.L. et al. (26 more authors) (2020) Ten-year mortality, disease progression, and treatment-related side effects in men with localised prostate cancer from the ProtecT randomised controlled trial according to treatment received. European Urology, 77 (3). pp. 320-330. ISSN 0302-2838

Hoddinott, P. orcid.org/0000-0002-4372-9681, Pollock, A., O'Cathain, A. orcid.org/0000-0003-4033-506X et al. (5 more authors) (2018) How to incorporate patient and public perspectives into the design and conduct of research [version 1; referees: 2 approved, 1 approved with reservations]. F1000Research, 7. 752. ISSN 2046-1402

Beard, D.J., Rees, J.L., Cook, J.A. et al. (46 more authors) (2018) Arthroscopic subacromial decompression for subacromial shoulder pain (CSAW): a multicentre, pragmatic, parallel group, placebo-controlled, three-group, randomised surgical trial. The Lancet, 391 (10118). pp. 329-338. ISSN 0140-6736

Johnston, T.J., Shaw, G.L., Lamb, A.D. et al. (29 more authors) (2017) Mortality Among Men with Advanced Prostate Cancer Excluded from the ProtecT Trial. European Urology, 71 (3). pp. 381-388. ISSN 0302-2838

Lane, A., Metcalfe, C., Young, G.J. et al. (9 more authors) (2016) Patient-reported outcomes in the ProtecT randomized trial of clinically localized prostate cancer treatments: Study design, and baseline urinary, bowel and sexual function and quality of life. BJU International, 118 (6). pp. 869-879. ISSN 1464-4096

Hamdy, F.C., Donovan, J.L., Lane, J.A. et al. (25 more authors) (2016) 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer. New England Journal of Medicine. ISSN 0028-4793

Donovan, J.L., Hamdy, F.C., Lane, J.A. et al. (36 more authors) (2016) Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer. New England Journal of Medicine. ISSN 0028-4793

Wade, J., Holding, P.N., Bonnington, S. et al. (11 more authors) (2015) Establishing nurse-led active surveillance for men with localised prostate cancer: development and formative evaluation of a model of care in the ProtecT trial. BMJ Open, 5 (9). e008953. ISSN 2044-6055

O’Cathain, A., Hoddinott, P., Lewin, S. et al. (7 more authors) (2015) Maximising the impact of qualitative research in feasibility studies for randomised controlled trials: guidance for researchers. Pilot and Feasibility Studies, 1. 32.

Al Olama, A.A., Benlloch, S., Antoniou, A.C. et al. (65 more authors) (2015) Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci. Cancer Epidemiology, Biomarkers and Prevention, 24 (7). pp. 1121-1129. ISSN 1055-9965

Wade, J., Rosario, D.J., Howson, J. et al. (9 more authors) (2015) Role of information in preparing men for transrectal ultrasound guided prostate biopsy: a qualitative study embedded in the ProtecT trial. BMC Health Services Research, 15. 80. ISSN 1472-6963

Macefield, R.C., Metcalfe, C., Lane, J.A. et al. (8 more authors) (2010) Impact of prostate cancer testing: an evaluation of the emotional consequences of a negative biopsy result. British Journal of Cancer, 102. pp. 1335-1340. ISSN 0007-0920

Tilling, K., Garmo, H., Metcalfe, C. et al. (12 more authors) (2010) Development of a new method for monitoring prostate-specific antigen changes in men with localised prostate cancer: A comparison of observational cohorts. European Urology, 57 (3). pp. 446-452. ISSN 0302-2838

Lane, J.A., Howson, J., Donovan, J.L. et al. (6 more authors) (2007) Detection of prostate cancer in unselected young men: prospective cohort nested within a randomised controlled trial. BMJ, 335 (7630). pp. 1139-1143. ISSN 0959-8146

Brindle, L.A., Oliver, S.E., Dedman, D. et al. (5 more authors) (2006) Measuring the psychosocial impact of population-based prostate-specific antigen testing for prostate cancer in the UK. BJU International, 98 (4). pp. 777-782. ISSN 1464-4096

Oliver, S.E., Barrass, B., Gunnell, D.J. et al. (7 more authors) (2004) Serum Insulin-Like Growth Factor-I Is Positively Associated With Serum Prostate-Specific Antigen in Middle-Aged Men Without Evidence of Prostate Cancer. Cancer Epidemiology Biomarkers & Prevention, 13 (1). pp. 163-165. ISSN 1055-9965

Oliver, S.E., Donovan, J.L., Peters, T.J. et al. (3 more authors) (2003) Recent trends in the use of radical prostatectomy in England: the epidemiology of diffusion. BJU International, 91 (4). pp. 331-336. ISSN 1464-4096

Proceedings Paper

Parker, A., Mills, N., Rooshenas, L. et al. (26 more authors) (2019) PS8A - O1: Staff training to improve participant recruitment into surgical randomised controlled trials: a feasibility study embedded within four randomised controlled trials. In: Trials. 5th International Clinical Trials Methodology Conference (ICTMC 2019), 06-09 Oct 2019, Brighton, UK. BMC , p. 579.